Diagnostic role of Xpert-MTB RIF assay in osteoarticular tuberculosis: A retrospective study

Abstract

BACKGROUND Osteoarticular tuberculosis (OATB) is a severe form of extrapulmonary tuberculosis (TB), which causes notable morbidity and warrants a high index of suspicion for prompt management. The diagnosis of OATB poses a challenge, because of the difficulty of collecting the samples and, secondarily, the paucibacillary nature of lesion, which gives poor sensitivity and reproducibility, with long turnaround time of routine/conventional laboratory tests and the requirement for invasive procedures and expertise. The Xpert MTB/RIF assay has been approved by the World Health Organization as a rapid diagnostic tool for diagnosing pulmonary and extrapulmonary TB. AIM To emphasize the diagnostic efficiency of gene Xpert for OATB in suspected patients in a tertiary care hospital of Eastern India. METHODS This retrospective study was conducted in the Department of Microbiology and Orthopaedics by analyzing the data of the gene Xpert assay over a 3-year duration from January 2018 to February 2021. Demographic and clinical data were recorded. The diagnostic efficiency of gene Xpert was evaluated against the composite reference standard (CRS). RESULTS A total of 37 cases fell into positive, probable, and possible categories of osteoarticular TB out of 112 patients included in the study by CRS; gene Xpert result was positive in 35 out of the 37 different CRS categorized cases. Of the 112 cases, culture was put in 40 cases, and, of these cultures, 5 cases showed the growth of MTB. Of these, 4 cases were included in the 35 cases diagnosed by gene Xpert. Smear microscopy was positive in 6 out of 37 CRS categorized cases. When compared with CRS, the sensitivity of gene Xpert assay, culture, and smear was found to be 94.6%, 13.5%, and 16.2%, respectively, while specificity in all the three types of tests was 100%. When kappa statistics were applied, the percentage of agreement gene Xpert, culture, and microscopy with CRS was found to be 95%, 20%, and 22.6%, respectively. Follow-up of the gene Xpert positive patients after getting anti-tubercular treatment revealed improved conditions. CONCLUSION Gene Xpert could detect 31 extra cases with a low and very low mycobacterial load that were missed by the routine culture methods. Hence, more samples should be processed for molecular diagnostic methods like gene Xpert along with other conventional methods for the validation of the molecular test prospectively for the timely diagnosis of osteoarticular TB.

Knowledge, Attitude, and Practices Among Healthcare Practitioners in the Context of Multidrug Resistance Tuberculosis: An Appraisal to Disease Elimination

“…Cartridge based nucleic acid amplification tests (CBNAAT) or the GeneXpert assay and TRUNAT (a chip based micro-PCR platform) assays are really helpful for the initial diagnosis of Rifampicin resistance, can also act as a surrogate marker for MDR TB. These tests are rapid, simpler and have high sensitivity and specificity [ 12 ]. In our survey, 88.8% of practitioners use GeneXpert for initial diagnosis.…”

Coinfection of Melioidosis and Tuberculosis Causing Infective Lumbar Spondylodiscitis

“…Finally, even in endemic countries like India, the government has come up with a recommendation to perform a biopsy whenever possible 12 . Molecular testing, such as the GenExpert (Cepheid), has made the diagnosis simple 24,25 . The pus can be obtained from more accessible sites, such as a psoas abscess in our case, which has become a routine for every patient with bright psoas on MRI.…”

Long-segment Continuous Multi-level Spinal Tuberculosis without Bony Destruction Leading to Rapid Paraplegia in an Immunocompetent Patient

“…Rapid molecular techniques such as GeneXpert MTB/ Rif assay have made the detection of MTB in STB easy, fast, and simple [ 11 ]. However, the main diagnostic dilemma in STB remains is sample collection from deeper sites, and paucibacillary nature of disease [ 12 ]. Chemotherapy is treatment for STB and surgery is indicated in selective cases [ 4 ] Nevertheless, recovery after rapid-onset paraplegia remains guarded [ 13 ].…”